| NCT ID | NCT07023510 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Defense Medical Center, Taiwan |
| Condition | Valvular Heart Disease Patients |
| Study Type | INTERVENTIONAL |
| Enrollment | 8,648 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 8,648 participants in total. It began in 2025-07-01 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if an artificial intelligence-powered electrocardiogram (AI-ECG) can help detect moderate or severe valvular heart diseases (VHD) in adults. The main question it aims to answer is: ．Can AI-ECG screening identify patients with significant heart valve diseases who may benefit from early echocardiography? Researchers will compare the rate of moderate or severe VHD detection between the experimental group and the control group to see if AI-ECG improve the detection rate of significant VHD. Participants will: * Be classified as high- or low-risk for VHD using an AI-ECG system * In the experimental group, high-risk participants will receive echocardiography based on AI-ECG results * In the control group, usual clinical care will be provided without routine echocardiography for AI-ECG high-risk results.
Eligibility Criteria
Inclusion Criteria: * At least one 12-lead ECG within 1 year * Age 60-85 years of age Exclusion Criteria: * Documented echocardiography within 3 years before indexed ECG * Any known valvular heart disease * History of any valvular surgery * Post-heart transplant
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07023510 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 85 Years, studying Valvular Heart Disease Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07023510 currently recruiting?
Yes, NCT07023510 is actively recruiting participants. Contact the research team at xup6fup0629@gmail.com for enrollment information.
Where is the NCT07023510 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07023510 clinical trial?
NCT07023510 is sponsored by National Defense Medical Center, Taiwan. The trial plans to enroll 8,648 participants.